Cardiorenal Benefits of GLP-1s Found in Type 1 Diabetes

by | May 19, 2026 | Health

A large database study shows lower risk for major adverse cardiovascular events and end-stage kidney disease, with no increase in adverse events.
Medscape Medical News

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments